The percentage of tumor‐infiltrated immune cells (CD45+CD3+ and CD45+IAIE+ cells) in tumors of oxTAA‐vaccinated mice did not change when compared to tumors from TAA‐vaccinated mice (Figure 3b). The gene discussed is PTPRC; the disease is neoplasm.